Valuation Collegium Pharmaceutical, Inc.

Stocks

Market Closed - Nasdaq Other stock markets 23:00:00 10/08/2026 +03			5-day change	1st Jan Change
27.20 ^USD	-7.70%		-23.55%	-41.25%

08-06	Collegium Pharmaceutical, Inc. Revises Earnings Guidance for the Year 2026	CI
08-06	Collegium Pharmaceutical, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	650	778.9	1,004	924	1,464	885.5	-	-
Change	-	19.82%	28.87%	-7.95%	58.4%	-39.5%	-	-
Enterprise Value (EV)	650	778.9	1,004	924	1,464	885.5	885.5	885.5
Change	-	19.82%	28.87%	-7.95%	58.4%	-39.5%	0%	0%
P/E	10x	-31.4x	23.9x	15.4x	26.8x	-	-	-
PBR	-	-	-	-	-	-	-	-
PEG	-	0x	-0x	0.3x	-3.83x	-	-	-
Capitalization / Revenue	2.35x	1.68x	1.77x	1.46x	1.88x	1.06x	1.07x	1.08x
EV / Revenue	0x	0x	0x	0x	0x	1.06x	1.07x	1.08x
EV / EBITDA	0x	0x	0x	0x	0x	1.94x	2.22x	2.58x
EV / EBIT	0x	0x	0x	0x	0x	1.96x	2.19x	2.35x
EV / FCF	-	-	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-	-	-
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	1.86	-0.74	1.29	1.86	1.73	-	-	-
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	276.9	463.9	566.8	631.4	780.6	836.8	828.1	820.2
EBITDA ¹	118.3	266	367	401.2	460.5	455.8	399.4	342.7
EBIT ¹	17.63	33.32	167	169.9	179.6	450.8	404.7	376.5
Net income	71.52	-25	48.16	69.19	62.87	-	-	-
Net Debt	-	-	-	-	-	-	-	-
Reference price ²	18.68	23.20	30.78	28.65	46.30	27.20	27.20	27.20
Nbr of stocks (in thousands)	34,797	33,572	32,611	32,250	31,611	32,556	-	-
Announcement Date	2/24/22 A	2/23/23 A	2/22/24 A	2/27/25 A	2/26/26 A	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
COLLEGIUM PHARMACEUTICAL, INC.	-	-	-	-	886M
ELI LILLY AND COMPANY	34.93x	12.78x	25.81x	0.56%	1,098B
JOHNSON & JOHNSON	29.12x	-	-	2.05%	631B
ABBVIE INC.	31.66x	7.38x	15.33x	2.77%	438B
ROCHE HOLDING AG	20.79x	4.93x	12.21x	2.68%	368B
NOVARTIS AG	22.24x	5.75x	14.34x	2.79%	298B
ASTRAZENECA PLC	20.77x	4.28x	12.16x	2.05%	251B
AMGEN INC.	26.18x	6.87x	12.22x	2.42%	226B
NOVO NORDISK A/S	13.88x	4.98x	10.54x	3.66%	209B
GILEAD SCIENCES, INC.	-41.32x	5.92x	33.42x	2.48%	165B
Average	17.58x	6.61x	17.00x	2.38%	368.52B
Weighted average by Cap.	25.00x	8.33x	18.79x	1.95%